Beam Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeBeam Therapeutics
Beam Therapeutics logo

Beam Therapeutics

0 followers

BEAM

Performance

About Beam Therapeutics

Beam Therapeutics is a biotechnology company focused on developing precision genetic medicines using base editing to treat genetic diseases. The company emphasizes clinically validated delivery technologies, including electroporation, nonviral and viral modalities, to advance its base editing programs. With operations in locations such as Cambridge, Massachusetts and Durham, North Carolina, Beam aims to expand the potential of gene-based editing and bring novel therapies to patients through pipelines and clinical trials.

Recent News

Recent Deals

Key Team Members

Amy Simon, M.D.

Chief Medical Officer

Giuseppe Ciaramella, Ph.D.

President

Sravan Emany

Chief Financial Officer

John Evans

Chief Executive Officer

Key Facts

HQ Location

Cambridge, United States

Founded

2017

Employees

501-1K

Status

Public

Website

https://beamtx.com